UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 14, 2011
ORTHOVITA, INC.
(Exact Name of Registrant Specified in Charter)
| | | | |
| Pennsylvania | | 0-24517 | | 23-2694857 |
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
| |
77 Great Valley Parkway Malvern, Pennsylvania | | 19355 |
| (Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s telephone, including area code: (610) 640-1775
(Former Name and Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
| ¨ | | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 7.01 | Regulation FD Disclosure |
On February 14, 2011, Orthovita, Inc. announced that that it will hold a conference call on Wednesday, March 9, 2011, at 8:30 a.m. Eastern Time, to review and discuss its financial results for the fourth quarter and year-end 2010 and provide financial guidance for 2011. Antony Koblish, President and Chief Executive Officer, and Nancy C. Broadbent, Senior Vice President and Chief Financial Officer of Orthovita, will host the call.
The telephone number to join the conference call is (888) 815-2919 from within the U.S., and (706) 643-3675 from outside the U.S. The conference identification number is 43723232. Participants should dial in ten minutes prior to the scheduled start time for the conference call.
A replay of the conference call will be available for two weeks beginning March 9, 2011, at 11:30 a.m. Eastern Time, and ending March 23, 2011, at 11:59 p.m. Eastern Time. To access the replay, dial (800) 642-1687 within the U.S. or (706) 645-9291 outside the U.S. The replay identification number is 43723232.
On February 16, 2011, Orthovita, Inc. issued a press releasing confirming that the launch date of its VITOSS™ Bioactive Foam-2X Bone Graft Substitute product in the United States will be February 16, 2011. A copy of the press release is included as Exhibit 99.2 to this report.
| Item 9.01 | Financial Statements and Exhibits |
| | |
Exhibit No. | | Description |
| |
| 99.1 | | Press Release, dated February 14, 2011, issued by Orthovita, Inc. |
| |
| 99.2 | | Press Release, dated February 16, 2011, issued by Orthovita, Inc. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
ORTHOVITA, INC. |
| |
| By: | | /s/ Christine J. Arasin |
| | Vice President and General Counsel |
Dated: February 16, 2011
